NCT00002753View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

November 30, 1991

Primary Completion Date

April 30, 2001

Study Completion Date

April 30, 2001

Conditions

Brain and Central Nervous System Tumors

Interventions

RADIATION

iodine I 131 monoclonal antibody 81C6

Trial Locations (1)

27710

Duke Comprehensive Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER

NCT00002753 - Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas | Biotech Hunter | Biotech Hunter